For decades W&H's sales team has been providing dental products and solutions to the US market. To further strengthen their global brand in North America, they have expanded their US team to deliver broader, more localized support in…

The United States Centers for Medicare & Medicaid Services announced that all employees of healthcare facilities that accept payment from Medicare and/or Medicaid must be vaccinated against COVID-19 by January 4, 2022. There is no…

StarAligners Promotes John Nabors to Vice President of Operations and Sales

Dentists can increase the profitability of their dental practice by understanding important financial principles, implementing solid planning strategies and by having the right people, processes and tools in place. In this episode of The…

The United States government committed to purchasing 1.7 million doses of molnupiravir—the Merck antiviral medication for COVID-19—in June, and has since increased its order by 1.4 million doses. Molnupiravir has been shown to decrease…

As the consistent growth in COVID-19 cases driven by the Delta variant seems to have abated, an analysis of this deadly surge is now possible. The most significant takeaway is that the unvaccinated faced the highest rates of morbidity and…

According to a study in The Lancet, COVID-19 brought more than viral illness, lockdowns, and business disruptions, it also led to an increase in mental health problems. Researchers reported 76 million more cases of anxiety disorders and 53…

One of the most significant unanswered questions of the global pandemic is why some people experience mild symptoms while others become seriously ill and even die. The answer may be in our genes. Researchers from the United Kingdom have…

On the heels of the United Kingdom’s authorization of a competing medication by Merck, Pfizer announced that its own antiviral drug designed to treat COVID-19 shows promising results. According to the company’s clinical trial on 775 adults…

The United Kingdom (UK) has authorized the use of an antiviral medication, molnupiravir, to reduce the severity of illness associated with COVID-19. Manufactured by the American pharmaceutical company, Merck, molnupiravir has been shown to…